Summary

Decellularization for the Preparation of Highly Preserved Human Acellular Skin Matrix for Regenerative Medicine

Published: September 08, 2021
doi:

Summary

Decellularized human skin is suitable for tissue regeneration. A major issue of decellularization is the preservation of the native architecture, along with the appropriate content of structural proteins, glycosaminoglycans (GAGs), and growth factors. The method proposed allows fast and effective decellularization, producing decellularized skin with well-preserved native features.

Abstract

Extracellular matrix (ECM) provides biophysical and biochemical stimuli to support self-renewal, proliferation, survival, and differentiation of surrounding cells due to its content of diverse bioactive molecules. Due to these characteristics, the ECM has been recently considered a promising candidate for the creation of biological scaffolds to boost tissue regeneration. Emerging studies have demonstrated that decellularized human tissues could resemble the native ECM in their structural and biochemical profiles, preserving the three-dimensional (3D) architecture and the content of fundamental biological molecules. Hence, decellularized ECM can be employed to promote tissue remodeling, repair, and functional reconstruction of many organs. Selecting the appropriate decellularization procedure is crucial to obtain acellular tissues that retain the characteristics of the ideal microenvironment for cells.

The protocol described here provides a detailed step-by-step description of the decellularization method to obtain a reproducible and effective cell-free biological ECM. Skin fragments from patients undergoing plastic surgery were scaled down and decellularized using a combination of sodium dodecylsulfate (SDS), Triton X-100, and antibiotics. To promote the regular and homogeneous transport of the solution through the samples, they were enclosed in embedding cassettes to ensure protection from mechanical insults. After the decellularization procedure, the snow-white color of skin fragments indicated complete and successful decellularization. Additionally, decellularized samples showed an intact and well-preserved architecture. The results suggest that the proposed decellularization method was effective, fast, and reproducible and protected samples from architectural damages.

Introduction

The ECM serves as a scaffold for cells, supporting them through an intricate architecture maintained by different components, and it is one of the major factors responsible for the mechanical properties of the heart and cardiac tissue function1,2. Increasing evidence suggests that ECM plays an active role in tissue remodeling, making the conventional assumption that the ECM is a passive component obsolete3,4,5,6. The role of the ECM is to provide biophysical and biochemical cues to resident cells. It is well-established that these signals can influence many fundamental cell behaviors, impacting their contractile function, proliferation, migration, and differentiation potential7,8,9. Thus, ECM is increasingly being employed in tissue engineering and regenerative medicine as a therapeutic support tool9,10,11,12,13.

The ECM consists of several proteins such as collagen, elastin, fibronectin, proteoglycan, and laminin, along with ECM-bound growth factors, all involved in regeneration mechanisms, such as cell recruitment, migration, and differentiation, as well as cell alignment and proliferation14. The mechanical properties of the tissues also have great relevance in the physiopathology of the organs. Indeed, changes in mechanical properties are often associated with the onset and the evolution of several diseases. The reason resides in the fact that when the ECM is modified, signals coming from the environment induce changes in gene and protein expression, leading to functional impairment15,16.

Regenerative therapies for organ repair are currently focused on replicating the sophisticated microenvironment of the native tissue to heal the organ where the body fails. Despite the rapid pace of many tissue engineering approaches, the tissues still cannot be reproduced accurately in their entirety and complexity by artificial procedures. Synthetic materials have been largely employed so far, as they can be appropriately tuned to simulate the mechanical and biochemical properties of the cellular microenvironment. Nevertheless, they have limits, such as the inability to mimic the numerous interactions within the native tissue, the cost of technologies to produce them, and the fact that they are less natural and biocompatible than native tissue17,18,19. Additionally, their composition, primarily in terms of proteins and soluble factors, greatly differs from the natural one, which is extremely difficult to replicate20.

The cutting-edge approach in regenerative medicine to reduce the gap between the patients in need and organ transplants is to produce scaffolds made of decellularized extracellular matrix (d-ECM) and repopulate them with the appropriate cell types to regenerate the damaged organs. Decellularization is the process in which the ECM is isolated from its native cells and genetic material to produce a natural and biomimetic scaffold, able to avoid the immune response and rejection once implanted in the patients21,22,23. The ECM thus obtained can then be repopulated to produce functional tissue. The major issue when developing a d-ECM is the method. For any decellularization technique, the primary goal remains the preservation of the native ECM composition, stiffness, and 3D structure, and all strategies have both benefits and drawbacks. Because the elimination of cellular content and DNA from the tissue requires the use of chemical or physical agents, or the combination of both, each decellularization procedure causes, to different degrees, the disruption of the ECM. Hence, it is crucial to minimize the damage to the ECM24,25,26.

Native ECM utilization as a platform for the reconstitution of native ECM in vitro is highly desirable. For this purpose, several decellularization protocols have been applied to a wide range of tissues27,28,29,30. In fact, since the early stages of decellularization research and ECM development, several tissues, such as arteries, aortic valves, and peripheral nerves from both animals and humans, have been decellularized, and some d-ECMs are still commercially available and used for tissue replacement or wound healing31,32,33. Recently, human skin has also emerged as a suitable candidate to produce decellularized scaffolds for cardiac repair owing to its composition and mechanical properties-able to boost the regenerative potential of cardiac progenitor cells (CPCs) and adapt to cardiac contractility34. This paper describes a simple and fast protocol to produce decellularized scaffolds from adult human skin, allowing the development of a d-ECM with well-preserved architecture.

Protocol

The specimens from human tissue were collected according to the principles of the Declaration of Helsinki and observing University Hospital "Federico II" guidelines. All patients involved in this study provided written consent forms. 1. Preparation of solutions Preparation of 1200 mL of 1% decellularizing solution Prepare 600 mL of 2% Triton X-100 solution by measuring 588 mL of double-distilled water in a graduated cylinder and transferring it to a 1 L beaker. …

Representative Results

The aim of the protocol was to obtain a skin d-ECM sample from biological tissue, maintaining a well-organized 3D structure and well-preserved content of biological molecules (Figure 1). This method is primarily based on the constant stirring of the samples in a solution containing the combination of two detergents, Triton X-100 and SDS, thus preserving the biological and structural features typical of the native tissue and reducing the time of exposure during the decellularization process. …

Discussion

Although the protocol described above has been optimized and improved compared to previously published protocols, it presents a few critical steps that need attention and precision. The formation of foam must be avoided during the preparation of the decellularizing solution to prevent incorrect dilution of the detergents. This could be addressed by gently pouring the solutions and making them flow along the inner side of the cylinder. Furthermore, care must be taken when manually removing fat tissue from the samples, as …

Divulgations

The authors have nothing to disclose.

Acknowledgements

None

Materials

0.9% NaCl isotonic Physiological solution Sigma-Aldrich S8776 0.9% in water
1 L beaker VWR 511-0318 Clean and autoclave before use
10 mL serological pipet Falcon 357551 Sterile,  polystyrene
100 mm plates Falcon 351029 Treated, sterile cell culture dish
15 mL sterile tubes Falcon 352097 Centrifuge sterile tubes, polypropylene
1 L graduated cylinder VWR 612-1524 Clean and autoclave before use
2 L bottle VWR 215-1596 Clean and autoclave before use
25 mL serological pipet Falcon 357525 Sterile,  polystyrene
2 L graduated cylinder VWR 612-3072 Clean and autoclave before use
500 mL beaker VWR 511-0317 Clean and autoclave before use
Amphotericin B Sigma-Aldrich Y0000005 Powder
Dissecting board VWR 100498-398 Made of high-density polyethylene.
Dissecting scalpel VWR 233-5526 Sterile and disposable
Embedding cassettes Diapath 070191 External dimensions: 40x26x7 mm (WxDxH)
Fine forceps VWR 232-1317 Clean and autoclave before use
Funnel VWR 221-1861 Clean and autoclave before use
Hexagonal weighing boats size M Sigma-Aldrich Z708585 Hexagonal, polystyrene, 51 mm Bottom I.D., 64 mm Top I.D.
Hexagonal weighing boats size S Sigma-Aldrich Z708577 Hexagonal, polystyrene, 25 mm Bottom I.D., 38 mm Top I.D.
Large surgical scissors VWR 233-1211 Clean and autoclave before use
Long forceps VWR 232-0096 Clean and autoclave before use
Penicillin and Streptomycin Sigma-Aldrich P4333-100ml Stabilized, with 10.000 units penicillin and 10 mg streptomycin/mL, 0.1 μm filtered. Store at -20°C.  The solution  should be aliquoted into smaller working volumes to avoid repeated freeze/thaw cycles Solution.
Pipette gun Eppendorf 613-2795 Eppendorf Easypet® 3
Plastic tray VWR BELAH162620000 Corrosion-proof polypropylene plastic tray
Potassium Chloride Sigma-Aldrich P9333 Powder
Potassium Phosphate Monobasic Sigma-Aldrich P5665 Powder
Sodium Chloride Sigma-Aldrich S7653 Powder
Sodium Dodecyl Sulfate Sigma-Aldrich 62862 Powder
Sodium Phosphate Dibasic Sigma-Aldrich 94046 Powder
Spatula VWR RSGA038.210 Clean and autoclave before use
Spoon VWR 231-1314 Clean and autoclave before use
Stir bar VWR 442-0362 Clean and autoclave before use
Stir bar retriever VWR 89026-262 Molded in pure, FDA-approved PTFE
Triton X-100 Sigma-Aldrich 9002-93-1 Liquid

References

  1. Daley, W. P., Peters, S. B., Larsen, M. Extracellular matrix dynamics in development and regenerative medicine. Journal of Cell Science. 121 (3), 255-264 (2008).
  2. Lu, P., Takai, K., Weaver, V. M., Werb, Z. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harbor Perspectives in Biology. 3 (12), 005058 (2011).
  3. Dobaczewski, M., Gonzalez-Quesada, C., Frangogiannis, N. G. The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. Journal of Molecular and Cellular Cardiology. 48 (3), 504-511 (2010).
  4. Frangogiannis, N. G. Matricellular proteins in cardiac adaptation and disease. Physiological Reviews. 92 (2), 635-688 (2012).
  5. Etoh, T., et al. Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs. American Journal of Physiology-Heart and Circulating Physiology. 281 (3), 987-994 (2001).
  6. Ma, Y., et al. Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling. Pflügers Archiv: European Journal of Physiology. 466 (6), 1113-1127 (2014).
  7. Fong, A. H., et al. Three-dimensional adult cardiac extracellular matrix promotes maturation of human induced pluripotent stem cell-derived cardiomyocytes. Tissue Engineering. Part A. 22 (15-16), 1016-1025 (2016).
  8. Atance, J., Yost, M. J., Carver, W. Influence of the extracellular matrix on the regulation of cardiac fibroblast behavior by mechanical stretch. Journal of Cell Physiology. 200 (3), 377-386 (2004).
  9. Belviso, I., et al. The microenvironment of decellularized extracellular matrix from heart failure myocardium alters the balance between angiogenic and fibrotic signals from stromal primitive cells. International Journal of Molecular Sciences. 21 (21), 7903 (2020).
  10. Badylak, S. F. Regenerative medicine and developmental biology: The role of the extracellular matrix. The Anatomical Record. 287 (1), 36-41 (2005).
  11. Volpato, F. Z., Führmann, T., Migliaresi, C., Hutmacher, D. W., Dalton, P. D. Using extracellular matrix for regenerative medicine in the spinal cord Using extracellular matrix for regenerative medicine in the spinal cord. Biomaterials. 34 (21), 4945-4955 (2013).
  12. Martino, M. M., et al. Extracellular matrix and growth factor engineering for controlled angiogenesis in regenerative medicine. Frontiers in Bioengineering and Biotechnology. 3, 45 (2015).
  13. Hussey, G. S., Keane, T. J., Badylak, S. F. The extracellular matrix of the gastrointestinal tract: a regenerative medicine platform. Nature Reviews: Gastroenterology Hepathology. 14, 540-552 (2017).
  14. Sheng, Y., Fei, D., Leiiei, G., Xiaosong, G. Extracellular matrix scaffolds for tissue engineering and regenerative medicine. Current Stem Cell Research and Therapy. 12 (3), 233-246 (2017).
  15. Rozario, T., De Simone, D. W. The extracellular matrix in development and morphogenesis: A dynamic view. Biologie du développement. 341 (1), 126-140 (2010).
  16. Takawale, A., Sakamuri, S. S. V. P., Kassiri, Z. Extracellular matrix communication and turnover in cardiac physiology and pathology. Comprehensive Physiology. 5 (2), 687-719 (2015).
  17. Li, L., Zhao, Q., Kong, W. Extracellular matrix remodeling and cardiac fibrosis. Matrix Biology. 68-69, 490-506 (2018).
  18. DeQuach, J. A., et al. Simple and high yielding method for preparing tissue specific extracellular matrix coatings for cell culture. PLoS ONE. 5 (9), 13039 (2010).
  19. Saldin, L. T., Cramer, M. C., Velankar, S. S., White, L. J., Badylak, S. F. Extracellular matrix hydrogels from decellularized tissue: Structure and function. Acta Biomaterialia. 49, 1-15 (2017).
  20. Tukmachev, D., et al. Injectable extracellular matrix hydrogels as scaffolds for spinal cord injury repair. Tissue Engineering. Part A. 22 (3-4), 306-317 (2016).
  21. Shoichet, M. S. Polymer scaffolds for biomaterials applications. Macromolecules. 43 (2), 581-591 (2010).
  22. Taylor, D. A., et al. Decellularized matrices in regenerative medicine. Acta Biomaterialia. 74, 74-89 (2018).
  23. Gilpin, A., Yang, Y. Decellularization strategies for regenerative medicine: From processing techniques to applications. BioMed Research International. 2017, 9831534 (2017).
  24. Heath, D. E. A review of decellularized extracellular matrix biomaterials for regenerative engineering applications. Regenerative Engineering and Translational Medicine. 5 (2), 155-166 (2019).
  25. Hoshiba, T., et al. Decellularized extracellular matrix as an in vitro model to study the comprehensive roles of the ECM in stem cell differentiation. Stem Cell International. 2016, 6397820 (2016).
  26. Keane, T. J., Swinehart, I. T., Badylak, S. F. Methods of tissue decellularization used for preparation of biologic scaffolds and in vivo relevance. Methods. 84, 5-34 (2015).
  27. Cerbotari, S., et al. Detergent decellularization of heart valves for tissue engineering: Toxicological effects of residual detergents on human endothelial cells. Artificial Organs. 34 (3), 206-210 (2010).
  28. Ott, H. C., et al. Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nature Medicine. 14 (2), 213-221 (2008).
  29. Uygun, B. E., et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nature Medicine. 16 (7), 814-820 (2010).
  30. Petersen, T. H., et al. Tissue-engineered lungs for in vivo implantation. Science. 329 (5991), 538-541 (2010).
  31. Calle, E. A., Petersen, T. H., Niklason, L. E. Procedure for lung engineering. Journal of Visualized Experiments. (49), e2651 (2011).
  32. Zeltinger, J., Landeen, L. K., Alexander, H. G., Kidd, I. D., Sibanda, B. Development and Characterization of Tissue-Engineered Aortic Valves. Tissue engineering. Part A. 7 (1), 9-22 (2001).
  33. Dahl, S., et al. Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplantation. 12 (6), 659-666 (2003).
  34. Belviso, I., et al. Decellularized human dermal matrix as a biological scaffold for cardiac repair and regeneration. Frontiers inTissue Engineering and Regenerative Medicine. 8, 229 (2020).
  35. Greco, K. V., et al. Characterisation of porcine dermis scaffolds decellularised using a novel non-enzymatic method for biomedical applications. Journal of Biomaterials Applications. 30 (2), 239-253 (2015).
  36. Brouki, M. P., et al. Decellularization and preservation of human skin: A platform for tissue engineering and reconstructive surgery. Methods. 171, 62-67 (2020).
  37. Carbonaro, D., et al. A low-cost scalable 3D-printed sample-holder for agitation-based decellularization of biological tissues. Medical Engineering & Physics. 85, 7-15 (2020).
  38. Di Meglio, F., et al. Optimization of human myocardium decellularization method for the construction of implantable patches. Tissue Engineering. Part C Methods. 23 (9), 525-539 (2017).
  39. Crapo, P. M., Gilbert, T. W., Badylak, S. F. An overview of tissue and whole organ decellularization processes. Biomaterials. 32 (12), 3233-3243 (2011).
  40. Putame, G., et al. Compact and tunable stretch bioreactor advancing tissue engineering implementation. Application to engineered cardiac constructs. Medical Engineering & Physics. 84, 1-9 (2020).
  41. Parmaksiz, M., Dogan, A., Odabas, S., Elçin, A. E., Elçin, Y. M. Clinical applications of decellularized extracellular matrices for tissue engineering and regenerative medicine. Biomedical Materials. 11 (2), 022003 (2016).
  42. Sacco, A. M., et al. Diversity of dermal fibroblasts as major determinant of variability in cell reprogramming. Journal of Cellular and Molecular Medicine. 23 (6), 4256-4268 (2019).
  43. Belviso, I., et al. Isolation of adult human dermal fibroblasts from abdominal skin and generation of induced pluripotent stem cells using a non-integrating method. Journal of Visualized Experiments: JoVE. (155), e60629 (2020).
  44. Belviso, I., Di Meglio, F., Romano, V., Montagnani, S., Castaldo, C. Non-modified RNA-based reprogramming of human dermal fibroblasts into induced pluripotent stem cells. Methods in Molecular Biology. , (2021).
This article has been published
Video Coming Soon
Keep me updated:

.

Citer Cet Article
Romano, V., Belviso, I., Cozzolino, D., Sacco, A. M., Schonauer, F., Nurzynska, D., Di Meglio, F., Castaldo, C. Decellularization for the Preparation of Highly Preserved Human Acellular Skin Matrix for Regenerative Medicine. J. Vis. Exp. (175), e62935, doi:10.3791/62935 (2021).

View Video